SCHEMBL8963705

SCHEMBL8963705

Cc1[nH]c(C(C)(C)C)nc1CN1CCN(C(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.52
ADORA3 P0DMS8 2/20 0.52
CNR1 P21554 2/20 0.52
HRH1 P35367 2/20 0.52
OPRK1 P41145 2/20 0.52
KCNH2 Q12809 2/20 0.52
GHSR Q92847 2/20 0.52
NR1I2 O75469 1/20 0.52
PDE4D Q08499 1/20 0.52
NPSR1 Q6W5P4 3/20 0.49
OPRD1 P41143 1/20 0.47
HTT P42858 3/20 0.47
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
CYP3A4 P08684 3/20 0.46
CYP2C19 P33261 2/20 0.46
CYP2C9 P11712 1/20 0.46
DRD2 P14416 2/20 0.46
DRD4 P21917 2/20 0.46
DRD3 P35462 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8963684 0.85 CYP3A4 (0.49) LMNAADORA3CNR1HRH1OPRK1
SCHEMBL8963465 0.82 LMNA (0.57) LMNAADORA3CNR1HRH1OPRK1
SCHEMBL8969984 0.82 LMNA (0.47) LMNAADORA3CNR1HRH1OPRK1
SCHEMBL8963668 0.82 DRD2 (0.64) LMNAADORA3CNR1HRH1OPRK1
SCHEMBL8963605 0.80 CYP3A4 (0.45) LMNAADORA3CNR1HRH1OPRK1
SCHEMBL8964163 0.80 DRD2 (0.51) LMNAADORA3CNR1HRH1OPRK1
SCHEMBL8963541 0.79 DRD2 (0.49) LMNAADORA3CNR1HRH1OPRK1
Lifarizine SCHEMBL676318 0.79 DRD2 (0.57) LMNAADORA3CNR1HRH1OPRK1
SCHEMBL8963644 0.78 DRD3 (0.56) LMNAADORA3CNR1HRH1OPRK1
Lifarizine SCHEMBL8963776 0.78 DRD2 (0.56) LMNAADORA3CNR1HRH1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514800-A CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA SYNTEX PHARMACEUTICALS, LTD. (GB) 1996-05-07 US disclosed
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 US disclosed
US-5252736-A Calcium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1993-10-12 US disclosed
US-5091428-A Calcium channel blockers preferential for cerebral blood vessels SYNTEX PHARMACEUTICALS, LTD. (BM) 1992-02-25 US disclosed
US-5043447-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1991-08-27 US disclosed
US-5010075-A Antiepilepic, hypotensive, antiarrhythmia, antiischemic agent SYNTEX PHARMACEUTICALS LTD. (GB) 1991-04-23 US disclosed
US-4935417-A CALCIUM CHANNEL BLOCKERS SYNTEX PHARMACEUTICALS LTD. (BM) 1990-06-19 US disclosed
US-4829065-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1989-05-09 US disclosed